Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Ping ZOU"'
Autor:
Zhiqiang Liu, Shu-Ping Zou, Kun Niu, Kepeng Lang, Zhong-Ce Hu, Wu Xuping, Yu-Guo Zheng, Qiang Fu
Publikováno v:
Journal of Applied Microbiology. 131:2849-2860
Aims Echinocandin B (ECB) is a kind of lipopeptide antifungal antibiotic, as well as the key precursor of antifungal drug Anidulafungin. Its efficient bioproduction plays an important role in promoting the industrial production of Anidulafungin. Meth
Publikováno v:
Bulletin of Entomological Research. 111:544-552
Salicylic acid (SA), a phytohormone, has been considered to be a key regulator mediating plant defence against pathogens. It is still vague how SA activates plant defence against herbivores such as chewing and sucking pests. Here, we used an aphid-su
Autor:
Shuanghu Wang, Aiping Deng, Ping Zou, Xueying Tan, Quan Zhou, Jinhui Wang, Jingbo Hu, Peiwu Geng
Publikováno v:
Drug Delivery and Translational Research. 12:167-179
Multidrug resistance (MDR) is considered as a critical limiting factor for the successful chemotherapy, which is mainly characterized by the overexpression of ATP-binding cassette (ABC) transporter ABCB1 or ABCG2. In this study, folate-targeted polym
Publikováno v:
Chemical Research in Toxicology. 34:70-79
Diclofenac sodium (DFS), a nonsteroidal anti-inflammatory drug, is frequently used in ophthalmology, but it causes negative effects on corneas. The mechanisms underlying the toxicities to corneas remains unclear. The present study was designed to ass
Autor:
Liang Liang Shi, Fan Zhou, Gui Fang Xu, Chang Zheng, Bin Zhang, Yuzheng Zhuge, Lei Wang, Xiao Ping Zou, Yi Wang
Publikováno v:
Molecular Cancer Research. 18:1491-1499
The R-spondin family plays important roles in embryonic development, including in humans. However, information on the relationship between R-spondin2 and hepatocellular carcinoma (HCC) is lacking. This study aimed was to explore the mechanisms of R-s
Autor:
Qing Li, Fanjun Cheng, Yi Xiao, Ping Zou, Xiaoying Zhu, Xiaojian Zhu, Shu Zhou, Weiming Li, Yong You, Zhaodong Zhong
Publikováno v:
Leukemia. 35:119-129
Chimeric antigen receptor (CAR) T-cell immunotherapy is rapidly emerging as a promising novel treatment for malignancies. To broaden the success of CAR T-cell treatment for chronic myeloid leukaemia (CML), we attempted to construct a CD26 CAR T-cell
Publikováno v:
Chinese Herbal Medicines. 12:133-141
Objective Lycopodiastrum casuarinoides, a fern of the Lycopodiaceae family, is a traditional Chinese medicine, which has similar efficacy to that of Huperzia serrata in treating rheumatoid arthritis (RA). However, they are different in the contents a
Autor:
Qi Shen, Qian Li, Pei-jin Lv, Zhiqiang Liu, Yu-Guo Zheng, Shu-Ping Zou, Zhuang Yu, Neng Xiong, Ya-Ping Xue
Publikováno v:
Applied Microbiology and Biotechnology. 104:2489-2500
1-Cyanocyclohexaneacetic acid (1-CHAA) is a critical intermediate for the synthesis of the antiepileptic agent gabapentin. Previously, our group has established a novel manufacturing route for 1-CHAA through bioconversion catalyzed by an Escherichia
Autor:
Ping Zou, Xiaoying Zhu, Shu Zhou, Yi Xiao, An-Yuan Guo, Wen Liu, Yong You, Xiaojian Zhu, Fanjun Cheng
Publikováno v:
Biochemical and Biophysical Research Communications. 522:362-367
Tyrosine kinase inhibitors (TKIs) that target BCR-ABL are the standard first-line therapy for patients with chronic-phase CML. However, TKIs cannot eliminate quiescent leukemia stem cells (LSCs) which persist in all patients on long-term therapy and
Autor:
Zhaodong Zhong, Xiaoying Zhu, Shu Zhou, Qing Li, Yong You, Xiaojian Zhu, Ping Zou, Fanjun Cheng, Na Shen, Na Wang
Publikováno v:
Immunopharmacology and Immunotoxicology. 41:490-496
Background: Immunotherapy utilizing T cells genetically modified to express chimeric antigen receptors (CARs) is rapidly emerging as a promising novel treatment for hematological and nonhematological malignancies. In order to target the TKI-insensiti